Buserelin shortens the estrus-to-ovulation interval and improves the pregnancy outcomes in gilts treated with a fixed-time artificial insemination

布舍瑞林可缩短发情至排卵间隔,并改善定时人工授精母猪的妊娠结局。

阅读:1

Abstract

Fixed-time artificial insemination (FTAI) is currently a standardized protocol for pig reproductive management. Efficient ovulation synchronization induced by GnRH analogs is critical for ensuring the pregnancy outcomes of FTAI. However, among the widely used GnRH analogs, the degree of synchronization and timing of ovulation remain unclear in gilts. In the present study, we focused on the estrus-to-ovulation interval, a key component in fertility management programs, and directly compared the follicular dynamics and timing of ovulation, and the subsequent pregnancy outcomes between two well-established GnRH analogs buserelin and gonadorelin. 224 prepubertal Large White gilts, randomly divided into three independent batches, were allotted to this study. The administration of PMSG was aligned with the FTAI protocol, with gonadorelin or buserelin injections administered upon detection of estrus onset in gilts. Ovarian ultrasonography was performed at the onset of estrus. Serum samples were collected for LH detection. Total piglets born, born alive, and other performance indicators were measured. Our results showed that buserelin-treated gilts exhibited an earlier ovulation, as well as a shorter estrus-to-ovulation interval and a centralized ovulation duration, with 81.5% ovulation occurring within 24-48 h after buserelin injection. Additionally, although the pregnancy rate and farrowing rate didn't differ between the two analogs, buserelin administration is beneficial for the number of total piglets and the piglet index. In conclusion, our data demonstrate that buserelin has advantages in centralizing induced ovulation and thus improving FTAI outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。